ÐÓ°ÉÔ­´´

AVROBIO logo

AVROBIO

Developing gene therapies to potentially cure rare diseases.

3

Funding Rounds

$85.0m

Money raised

Overview

Developing gene therapies to potentially cure rare diseases.
  • Websites:
  • Business model: B2B B2C
  • Headquarters: Cambridge, Massachusetts
  • Social accounts:

Funding series

Funding Series Analysis

The company AVROBIO has raised a total of $25m in funding over 3 rounds.

Key Insights:

  • AVROBIO Series A round, August 2, 2016: $25m
  • Avrobio funding round, February 2018: $60m
AVROBIO logo
AVROBIO Series A round, August 2, 2016 $25m
AVROBIO logo
Avrobio funding round, February 2018 $60m